Biogen Inc.
BIIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $22 | $37 | $40 | $36 |
| - Cash | $2 | $1 | $3 | $2 |
| + Debt | $7 | $7 | $7 | $8 |
| Enterprise Value | $27 | $44 | $43 | $41 |
| Revenue | $10 | $10 | $10 | $11 |
| % Growth | -1.6% | -3.3% | -7.4% | – |
| Gross Profit | $7 | $7 | $8 | $9 |
| % Margin | 76.1% | 74.2% | 77.6% | 80.8% |
| EBITDA | $3 | $2 | $4 | $4 |
| % Margin | 31% | 24.2% | 34.8% | 35.7% |
| Net Income | $2 | $1 | $3 | $2 |
| % Margin | 16.9% | 11.8% | 29.9% | 14.2% |
| EPS Diluted | 11.19 | 7.97 | 20.87 | 10.4 |
| % Growth | 40.4% | -61.8% | 100.7% | – |
| Operating Cash Flow | $3 | $2 | $1 | $4 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $3 | $1 | $1 | $3 |